Citations

Mayo Clinic

Clear

587 citation(s) found for "Xu, Ding".

P4‐142: Contact Factors Differ for Dementia and Amnestic MCI in Chinese Elders: The Pilot SCOBHI Study.
Hong, Risk Zhen, Borenstein, Amy R., Mortimer, James A., Ding, Ding , Guo, Qihao , Salmon, David P. , Petersen, Ronald, Zhao, Qianhua , Galasko, Douglas

Alzheimer's & Dementia | October 26, 2010 | Volume: 6 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2010.08.201 Get It

Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
Knox, Traci R., Tschumper, Renee C. , Schwager, Susan M., Boysen, Justin C. , Jelinek, Diane F., Ding, Wei , Wu, Wenting , Kay, Neil E.

Blood | July 6, 2010 | Volume: 116 | Issue: 16 | Pages: 2984-2993

10.1182/blood-2010-02-269894 | PMID 20606160 Get It

Abstract Malignant cells are capable of influencing the microenvironment in a manner that facilitates tumor cell survival. Bidirectional crosstalk between chronic lymphocytic leukemic (CLL) cells and marrow-derived mesenchymal stromal cells (MSCs) activates both cell types. In this study, we observed that the conditioned medium (CM) obtained from CLL cells was able to induce Akt activation in MSC. Subsequent studies investigated the mechanism of MSC activation mediated by CLL-CM. Platelet-derived growth factor receptors (PDGFRs) were selectively activated in MSCs by CLL-CM and found to be critical receptors for CLL-CM–driven MSC proliferation and MSC Akt activation. The known ligands of PDGFR, platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), were detected in CLL-CM, but PDGF was the predominant ligand involved in the CM-mediated PDGFR activation. Both PDGF and VEGF were found to be elevated in the plasma of CLL patients with a positive association for high-risk factors and more advanced stage. Finally, we demonstrated that PDGF induced MSC VEGF production through a phosphatidylinositol 3-kinase (PI3K)–dependent mechanism. These results show that PDGF-PDGFR signaling influences at least the MSC in the microenvironment of CLL and may play a role in the induction of an angiogenic switch known to be permissive for disease progression.
Sensitivity of CFD Based Hemodynamic Results in Rabbit Aneurysm Models to Idealizations in Surrounding Vasculature
Zeng, Zijing, Kallmes, David F. , Durka, Michael J. , Lewis, Debra A., Kadirvel, Ramanathan , Robertson, Anne M. , Ding, Yonghong , Robertson, Anne M

Journal of Biomechanical Engineering | April 26, 2010 | Volume: 132 | Issue: 9 | Pages: No page available

10.1115/1.4001311 | PMID 20815643 Get It

Computational fluid dynamics (CFD) studies provide a valuable tool for evaluating the role of hemodynamics in vascular diseases such as cerebral aneurysms and atherosclerosis. However, such models necessarily only include isolated segments of the vasculature. In this work, we evaluate the influence of geometric approximations in vascular anatomy on hemodynamics in elastase induced saccular aneurysms in rabbits. One representative high aspect ratio (AR—height/neck width) aneurysm and one low AR aneurysm were created at the origin of the right common carotid artery in two New Zealand white rabbits. Three-dimensional (3D) reconstructions of the aneurysm and surrounding arteries were created using 3D rotational angiographic data. Five models with varying extents of neighboring vasculature were created for both the high and low AR cases. A reference model included the aneurysm sac, left common carotid artery (LCCA), aortic arch, and downstream trifurcation/quadrification. Three-dimensional, pulsatile CFD studies were performed and streamlines, wall shear stress (WSS), oscillatory shear index, and cross sectional velocity were compared between the models. The influence of the vascular domain on intra-aneurysmal hemodynamics varied between the low and high AR cases. For the high AR case, even a simple model including only the aneurysm, a small section of neighboring vasculature, and simple extensions captured the main features of the steamline and WSS distribution predicted by the reference model. However, the WSS distribution in the low AR case was more strongly influenced by the extent of vasculature. In particular, it was necessary to include the downstream quadrification and upstream LCCA to obtain good predictions of WSS. The findings in this work demonstrate the accuracy of CFD results can be compromised if insufficient neighboring vessels are included in studies of hemodynamics in elastase induced rabbit aneurysms. Consideration of aspect ratio, hemodynamic parameters of interest, and acceptable magnitude of error when selecting the vascular domain will increase reliability of the results while decreasing computational time.
Effects of Apolipoprotein E-ε4 and -ε2 in Amnestic Mild Cognitive Impairment and Dementia in Shanghai: SCOBHI-P
Borenstein, Amy R., Mortimer, James A., Ding, Ding , Schellenberg, Gerard D. , DeCarli, Charles, Copenhaver, Cathleen, Guo, Qihao , Chu, Shugang, Salmon, David P. , Wu, Yougui , Petersen, Ronald C. , Hong, Zhen , DeCarli, Charles , Ding, Ding , Zhao, Qianhua , Galasko, Douglas , Dai, Qi , DeCarli, Charles

American Journal of Alzheimer's Disease & Other Dementias® | February 8, 2010 | Volume: 25 | Issue: 3 | Pages: 233-238

10.1177/1533317509357736 | PMID 20142627 Get It

Objective: To determine apolipoprotein E (APOE)-ε4 and -ε2 frequencies and risk of mild cognitive impairment (MCI) and dementia in Shanghai, China. Methods: A total of 34 MCI and 34 dementia cases were recruited from an urban Memory Disorders Clinic and 32 controls were recruited from a residential community served by the clinic. Apolipoprotein E was genotyped using standard methods. Results: Among controls, frequencies were ε2, 0.11; ε3, 0.84; and ε4, 0.05; among MCI, 0.05, 0.77, and 0.18; and for dementia, 0.02, 0.84, and 0.15, respectively. In education-adjusted models, the odds ratio (OR) = 5.6 for dementia (95% CI = 1.09-29.3) and 4.7 for MCI (95% CI = 0.90-25.2) associated with any ε4 allele. The ε2 allele was inversely associated with dementia (OR = 0.12, 95% CI = 0.013-0.997) and MCI (OR = 0.38, 95% CI = 0.08-1.61). Conclusions: APOE-ε4 increases and -ε2 decreases the risk of dementia vs normal cognition. Similar trends were observed for amnestic mild cognitive impairment (aMCI).
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression
Ghosh, Asish K. , Secreto, Charla, Knox, Traci R., Ding, Wei , Mukhopadhyay, Debabrata , Kay, Neil E.

Blood | December 18, 2009 | Volume: 115 | Issue: 9 | Pages: 1755-1764

10.1182/blood-2009-09-242719 | PMID 20018914 Get It

Abstract Microvesicles (MVs) released by malignant cancer cells constitute an important part of the tumor microenvironment. They can transfer various messages to target cells and may be critical to disease progression. Here, we demonstrate that MVs circulating in plasma of B-cell chronic lymphocytic leukemia (CLL) patients exhibit a phenotypic shift from predominantly platelet derived in early stage to leukemic B-cell derived at advanced stage. Furthermore, the total MV level in CLL was significantly greater compared with healthy subjects. To understand the functional implication, we examined whether MVs can interact and modulate CLL bone marrow stromal cells (BMSCs) known to provide a “homing and nurturing” environment for CLL B cells. We found that CLL-MV can activate the AKT/mammalian target of rapamycin/p70S6K/hypoxia-inducible factor-1α axis in CLL-BMSCs with production of vascular endothelial growth factor, a survival factor for CLL B cells. Moreover, MV-mediated AKT activation led to modulation of the β-catenin pathway and increased expression of cyclin D1 and c-myc in BMSCs. We found MV delivered phospho-receptor tyrosine kinase Axl directly to the BMSCs in association with AKT activation. This study demonstrates the existence of separate MV phenotypes during leukemic disease progression and underscores the important role of MVs in activation of the tumor microenvironment.
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
Hsieh, Ting–Hui, Liu, Chun‐Jen , Lai, Ming–Yang, Chen, Pei‐Jer , Hsieh, Hsin-Ling , Chen, Ding‐Shinn , Kao, Jia‐Horng , Tseng, Tai‐Chung

Antiviral Therapy | November 27, 2009 | Volume: 14 | Issue: 8 | Pages: 1157-1163

10.3851/imp1454 | PMID 20032545 Get It

Background Hepatitis B virus (HBV) genotype B and C seem not to affect the therapeutic response to lamivudine (3TC). Whether a given genotype has an earlier emergence of 3TC resistance remains unclear. We thus conducted this study to elucidate the association of HBV genotype with the emergence of 3TC-resistant strains in Taiwanese patients. Methods Forty chronic hepatitis B patients who developed resistance after 3TC therapy were retrospectively enrolled. HBV genotype, serum alanine aminotransferase (ALT) and HBV DNA levels were determined at baseline. The presence of 3TC-resistant mutations was confirmed by direct sequencing whenever biochemical breakthrough developed. Results The distribution of HBV genotype B and C in 40 patients receiving 3TC therapy were 60% and 40%, respectively. The mean interval to detect 3TC- resistant strain was 19.6 ±1.7 months. By using multivariate analysis, HBV genotype B and higher pre-treatment HBV DNA level were independently associated with earlier detection of 3TC-resistant strains. In addition, genotype B was significantly associated with development of 3TC resistance within the first 12 months of 3TC therapy compared with genotype C (odds ratio 8.27; P=0.004). Conclusions Compared with HBV genotype C, genotype B appears to have an earlier biochemical resistance to 3TC than genotype C. Therefore, more frequent monitoring of viral load or genotypical resistance might be needed for patients with HBV genotype B infection receiving 3TC therapy, especially during the first year.
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
Kurtova, Antonina V., Balakrishnan, Kumudha, Chen, Rong , Schnabl, Susanne, Quiroga, Maite P., Sivina, Mariela , Keating, Michael J. , Shehata, Medhat , Jäger, Ulrich, Ding, Wei , Wierda, William G. , Estrov, Zeev E. , Gandhi, Varsha V. , Kay, Neil E. , Plunkett, William K. , Burger, Jan A.

Blood | September 18, 2009 | Volume: 114 | Issue: 20 | Pages: 4441-4450

10.1182/blood-2009-07-233718 | PMID 19762485 Get It

Abstract Marrow stromal cells (MSCs) provide important survival and drug resistance signals to chronic lymphocytic leukemia (CLL) cells, but current models to analyze CLL–MSC interactions are heterogeneous. Therefore, we tested different human and murine MSC lines and primary human MSCs for their ability to protect CLL cells from spontaneous and drug-induced apoptosis. Our results show that both human and murine MSCs are equally effective in protecting CLL cells from fludarabine-induced apoptosis. This protective effect was sustained over a wide range of CLL–MSC ratios (5:1 to 100:1), and the levels of protection were reproducible in 4 different laboratories. Human and murine MSCs also protected CLL cells from dexamethasone- and cyclophosphamide-induced apoptosis. This protection required cell–cell contact and was virtually absent when CLL cells were separated from the MSCs by micropore filters. Furthermore, MSCs maintained Mcl-1 and protected CLL cells from spontaneous and fludarabine-induced Mcl-1 and PARP cleavage. Collectively, these studies define common denominators for CLL cocultures with MSCs. They also provide a reliable, validated tool for future investigations into the mechanism of MSC–CLL cross talk and for drug testing in a more relevant fashion than the commonly used suspension cultures.
P3‐227: Perception of stigma and willingness to participate in a cohort study among proxy respondents and controls in Shanghai, China: Scobhi‐pilot
Copenhaver, Cathleen, Ding, Ding , Mortimer, James A., Guo, Qihao , Salmon, David P. , Petersen, Ronald, Hong, Zhen , Borenstein, Amy R., Zhao, Qianhua , Galasko, Douglas , Wu, Yougui , Dai, Qi

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_13 | Pages: No page available

10.1016/j.jalz.2009.04.1000 Get It

S3‐03‐04: Prevalence study in Shanghai
Ding, Ding , Hong, Zhen , Mortimer, James A., Chu, Shuguang , Salmon, David P. , Petersen, Ronald, Borenstein, Amy R., Zhao, Qianhua , DeCarli, Charles , Galasko, Douglas

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2009.05.659 Get It

IC‐P‐025: Shanghai community brain health initiative pilot study: Neuropsychological results
Ding, Ding , Guo, Qihao , Mortimer, James A., Copenhaver, Cathleen, Salmon, David P. , Galasko, Douglas, DeCarli, Charles , Petersen, Ron, Borenstein, Amy R., Zhao, Qianhua , Ding, Ding , Dai, Qi , Wu, Yougui , Hong, Zhen

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2009.05.045 Get It